NRXP
NASDAQ · Pharmaceuticals
Nrx Pharmaceuticals Inc
$3.85
-0.05 (-1.28%)
Open$3.83
Previous Close$3.90
Day High$3.93
Day Low$3.77
52W High$5.06
52W Low$1.62
Volume—
Avg Volume1.15M
Market Cap166.51M
P/E Ratio—
EPS$-1.28
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+452.7% upside
Current
$3.85
$3.85
Target
$21.28
$21.28
$14.65
$21.28 avg
$27.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.36M | 21.55M | 19.28M |
| Net Income | -55,122,993 | 2.70M | 1.92M |
| Profit Margin | -2,336.5% | 12.5% | 10.0% |
| EBITDA | -43,050,670 | 4.73M | 4.55M |
| Free Cash Flow | — | 2.93M | 1.59M |
| Rev Growth | — | +2.0% | +3.7% |
| Debt/Equity | 1.42 | 0.67 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,114.20 | +0.64% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $240.15 | +0.45% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $121.17 | +1.31% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.09 | -2.55% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.15 | +1.70% | 12.5 | 33.00B |